Fundraising Fox

Courier Health

New York City, US · Founded 2020 · Delaware corporation · 147 employees on LinkedIn · 4 known investors

Courier Health provides a software platform for biopharma companies to manage and optimize patient engagement and support throughout the treatment journey. The platform enables manufacturers to improve patient starts, time-to-treatment, and medication adherence in chronic and rare disease care.

Also known as Courier Health, Inc.

Founders & leadership

DS
Danny SigurdsonCEO
JW
James W. PomponioNamed on SEC filing

Investors · 4

Also in the syndicate · 1

Norwest

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 1 of 2 rounds · 2021–2026

$4MraisedAug 2021 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • James W. PomponioExecutive Officer, Director
  • Daniel SigurdsonExecutive Officer, Director
Offering amount
$4M
Amount sold
$4M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Courier Health, Inc. is a New York City-based software company that provides biopharma and life sciences companies with a platform to manage the end-to-end patient journey, from education and enrollment through benefits verification and prior authorization to therapy initiation and long-term adherence. The company positions its product as a purpose-built patient CRM and "patient experience command center" that unifies disparate data sources and systems to give manufacturers a 360-degree view of each patient, coordinate next best actions across internal and external teams, and monitor program performance in real time.

The platform is organized around two primary use cases: a command center for Field Access (Access & Reimbursement teams) and a backbone for Patient Services. Capabilities include unified patient dashboards, omnichannel communication (telephone, SMS, email, fax and eSign within one system), workflow automation, risk scoring and predictive AI to flag at-risk patients, providers and programs, AI-generated patient summaries, AI agents that execute tasks, multi-therapy configuration, roles-based access controls and compliance enforcement, and real-time API integrations with partner systems including prior authorization, benefit investigation/verification, EHR, hubs and specialty pharmacies. The company states the platform is SOC 2 certified and HIPAA compliant.

Alongside its software, Courier Health publishes The State of Patient-Centricity in Biopharma report (2026 edition based on input from 170+ biopharma commercial leaders), hosts the invite-only Patient Innovators Summit, and runs the annual Patient Innovators Awards.

Founding story

The founding team focused on the complexity of the U.S. healthcare system and the specific challenges faced by biopharma commercial end users, and built a platform focused entirely on biopharma commercial teams. Danny Sigurdson is identified as founder and CEO.

Business model

Courier Health sells enterprise SaaS to biopharma manufacturers, offering an integrated platform that replaces or supplements customizable "big box" CRM tools, along with implementation expertise and ongoing support; the platform is licensed and configurable across multiple therapies from a single system.

Revenue derives from software sales to biopharma companies that license the patient experience platform across their programs and therapies.

Traction

The company reports platform impact figures of more than 15% increase in patient starts, more than 10% increase in 6-month persistency, 67% reduction in time-to-start, and 7x team productivity/efficiency gains. In 2025 it grew the number of customers and therapies supported on the platform by over 400% and more than doubled headcount.

Latest developments

On April 22, 2026, Courier Health announced a $50 million Series B round led by Oak HC/FT with participation from existing investors Norwest and Work-Bench, to be used for product innovation, scaling the platform and agentic AI capabilities, and team investment. The company also released the 2026 edition of The State of Patient-Centricity in Biopharma report and opened nominations for the second annual Patient Innovators Awards.

Full profile — market position, technology, go-to-market, geography, history

Market position

Courier Health describes itself as the patient experience company for life sciences and the leading purpose-built solution for orchestrating and personalizing patient journeys; an Oak HC/FT partner stated that life sciences has lacked a dedicated, purpose-built platform to manage patients. Its clients range from small biotechs launching a first specialty treatment to large specialty companies with diverse product portfolios.

The company emphasizes that its platform is 100% focused on biopharma commercial teams rather than a general-purpose CRM requiring costly customization, with built-in omnichannel channels that avoid additional vendor contracts, industry-specific integrations (PA, BI/BV, EHR, hub and specialty pharmacy systems), predictive AI and risk scoring, multi-therapy support, and built-in compliance features such as consent capture, HIPAA obfuscation, SSO and MFA.

Technology

The system combines deep data integrations, intelligent workflows driven by context-rich AI, interfaces designed for market access and patient services teams, and AI agents that execute key tasks for automation and scale. Additional elements include AI-generated patient summaries, predictive analytics and risk scoring, real-time APIs, in-platform reporting, secure document storage, and SOC 2 certification with HIPAA compliance and 24/7 monitoring.

Go-to-market

Direct enterprise sales through website contact and sales conversations, supported by content marketing including the State of Patient-Centricity in Biopharma report, the invite-only Patient Innovators Summit, and the Patient Innovators Awards program, plus client testimonials from market access and patient services executives.

Biopharma and life sciences manufacturers of all sizes and therapeutic areas, specifically their Field Access, Patient Services, Marketing and Sales teams, supporting patients with chronic conditions and rare diseases.

Geography

Headquartered in New York City, with offices in Manhattan's NoMad neighborhood; the company operates as an office-first employer with in-person collaboration four days per week and focuses on the U.S. healthcare market.

History

Company materials state Courier Health was founded in 2021 and builds biopharma patient engagement and support software from offices in New York City. Prior investors include Norwest and Work-Bench. In 2025 the company reported growing customers and therapies supported on the platform by over 400% and more than doubling headcount. In April 2026 it announced a $50 million Series B round led by Oak HC/FT.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Biopharma commercial leaders surveyed for State of Patient-Centricity reportJan 2026170 leaders
Growth in customers and therapies supported on platformJan 2025over 400% increase in 2025
HeadcountAug 2026147
Headcount growthJan 2025more than doubled in 2025
Increase in 6-month persistency (client outcome)Jan 2026>10%
Increase in patient starts (client outcome)Jan 2026>15%
Reduction in time-to-start (client outcome)Jan 202667%
Team productivity/efficiency gain (client outcome)Jan 20267x

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 5

by search overlap
Definitive Healthcare69 shared keywordsDefinitive Healthcare provides a healthcare commercial intelligence platform with all-payor claims data, reference data, and analytics on hospitals, physicians, payors, procedures, diagnoses, and prescriptions. It serves life sciences companies, healthcare providers, and healthcare-adjacent businesses for market analysis, targeting, and sales and marketing efforts, with an AI-powered intelligence product announced for Winter 2026.
IQVIA55 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
EMITRR* Local Services34 shared keywordsEmitrr provides a communication platform for businesses that includes text-enabled business phone lines, team messaging, appointment scheduling and reminders, review generation, bulk SMS/MMS, and website lead-capture forms. It aims to reduce inbound phone calls and manage customer communications from a single platform.
Creatio33 shared keywordsCreatio is an AI-native CRM and workflow automation platform that enables users to build agents and applications through AI coding agents and no-code visual designers. It serves marketing, sales, and service teams across various industries with capabilities for lead management, sales force automation, and business process management.
Cured33 shared keywordsCured builds cloud-based enterprise software for healthcare organizations to modernize operations and improve patient and employee experiences. The company provides technology solutions that enable healthcare providers and payers to execute strategic initiatives through agile, consumer-grade platforms.

Companies competing with Courier Health for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 3

launches, deals, and filings
Apr 2026
Courier Health raises $50 million Series B led by Oak HC/FT

Courier Health announced a $50 million Series B round led by Oak HC/FT with participation from existing investors Norwest and Work-Bench, to fund product innovation, platform and agentic AI capabilities, and team growth.

$50M source ↗

Jan 2026
Release of 2026 State of Patient-Centricity in Biopharma report

Courier Health released the 2026 edition of The State of Patient-Centricity in Biopharma report, based on insights from 170+ biopharma commercial leaders; it found nearly 60% of biopharma companies consider their data fragmented or inactionable and less than 10% have sufficient data maturity to leverage AI meaningfully.

source ↗

Jan 2025
2025 Patient Innovators Awards winners announced

Courier Health announced the winners of the 2025 Patient Innovators Awards; the second annual awards program was open for nominations as of 2026.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
Courier HealthDelaware

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Courier Health do?
Courier Health builds an AI-powered patient experience and CRM platform for biopharma field access and patient services teams.
Who are Courier Health's investors?
Courier Health's investors include Oak HC/FT, Work-Bench, Norwest Venture Partners.
How much funding has Courier Health raised?
Courier Health has disclosed $4M raised across 1 of its 2 known rounds.
Where is Courier Health headquartered?
Courier Health is headquartered in New York City, US.